El interés en corto de Portage Biotech da a los inversores una idea del grado en que los inversores apuestan por la caída de las acciones de Portage Biotech. Los datos de interés en corto se actualizan cada dos semanas.

Portage Biotech (NASDAQ:PRTG) Bolsa, Informe de interés en corto

Portage Biotech

Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.

Earnings

News

Markets

Trading Ideas

APDN

AUID

CERO

COMM

CRVS

EFSH

FSBW

NIVF

NUKK

PRTG

PRZO

PTPI

RZLV

SHLT

SSBK

TNXP

VSTE

Acciones de Corvus suben un 22,5% pre-market tras anunciar datos de Soquelitinib. Descubre más ganadores y perdedores.

Acciones de Corvus Pharmaceuticals (CRVS) suben alrededor del 22%; 20 acciones que se mueven en premercado

Portage Biotech Inc

Hut 8 Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HUT#NASDAQ">HUT</a>) shares are trading lower Monday, potentially after the company announced it is spinning off its Bitcoin mining operations into a new entity, American Bitcoin, <a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44560290/trump-family-to-dive-into-bitcoin-mining-after-defi-meme-coin-projects">in partnership with Eric Trump</a>.
What To Know: Hut 8 transferred most of its ASIC miners to American Bitcoin in exchange for an 80% stake. The new company aims to become the largest Bitcoin miner with a target of 50+ exahashes per second and plans to build a strategic Bitcoin reserve. It also intends to go public.
American Bitcoin will operate under Hut 8's Compute segment, but Hut 8 will manage its infrastructure and operations under long-term agreements. This allows Hut 8 to focus on infrastructure while American Bitcoin handles mining.
The leadership team includes Mike Ho as Executive Chairman, Matt Prusak as CEO and Eric Trump as Chief Strategy Officer. The board includes Ho, Hut 8 CEO Asher Genoot, Justin Mateen and Michael Broukhim.
Eric Trump and Donald Trump Jr. said the deal supports Bitcoin and decentralized finance. Hut 8's CEO said the spin-off allows each business to raise capital separately.
Price Action: Hut 8 shares are down 0.81% at $11.63 at the time of writing, according to Benzinga Pro.
<figure class="wp-block-image size-large is-resized"><a href="https://pro.benzinga.com/dashboard?new_user=False&amp;backend=google-oauth2"><img loading="lazy" decoding="async" width="1024" height="504" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/31141848/Screenshot-2025-03-31-at-14.18.21-1024x504.png" alt="" class="wp-image-849783" style="width:435px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/31141848/Screenshot-2025-03-31-at-14.18.21-1024x504.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/31141848/Screenshot-2025-03-31-at-14.18.21-300x148.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/31141848/Screenshot-2025-03-31-at-14.18.21-768x378.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/31141848/Screenshot-2025-03-31-at-14.18.21.png 1511w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44567164/circle-eyes-5-billion-valuation-for-upcoming-initial-public-offering">Circle Eyes $5 Billion Valuation For Upcoming Initial Public Offering</a></li>
</ul>
Image Via Shutterstock.

Movers

Hut 8 Shares Are Down Today: What's Going On?

Advanced Micro Devices, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) announced on Monday that <a target="_blank" href="https://www.benzinga.com/pressreleases/25/03/g44560854/powered-by-5th-gen-amd-epyc-cpus-oracle-cloud-infrastructure-compute-e6-shapes-deliver-breakthroug" rel="noreferrer noopener">fifth-generation AMD EPYC processors</a> power the Oracle Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) Oracle Cloud Infrastructure (OCI) Compute E6 Standard shapes.
The fifth&nbsp;generation AMD EPYC processors, the world&#8217;s best server CPUs for enterprise, AI, and cloud, enable OCI Compute E6 shapes to deliver up to a 2 times increase in cost to performance, compared to the previous E5 instance generation based on testing by OCI.
The new OCI Compute E6 shapes build on the success of the previous E5 generation to deliver leadership performance and cost efficiency for general-purpose and compute-intensive workloads.
Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-ratings/price-target/25/02/43788975/amd-closing-competitive-gpu-gap-with-nvidia-gains-market-share-from-intel-in-client-and-server-markets-analyst" rel="noreferrer noopener">AMD Closing Competitive GPU Gap With Nvidia, Gains Market Share From Intel In Client And Server Markets: Analyst</a>
AMD senior vice president and general manager Dan McNamara noted the combination of OCI&#8217;s flexible infrastructure and the performance of fifth&nbsp;Gen AMD EPYC processors helps customers accelerate their most demanding workloads while optimizing their cloud infrastructure.
OCI Compute E6 Standard bare metal instances and virtual machines are available in regions, including the US East (Ashburn), US West (Phoenix), US Midwest (Chicago), Germany Central (Frankfurt), and UK South (London). A rollout is planned for additional regions in the coming months.
AMD stock plunged 45% in the last 12 months.
In March, Jefferies analyst&nbsp;Blayne Curtis <a target="_blank" href="https://www.benzinga.com/25/03/44511459/amd-stock-falls-nearly-3-in-thursday-pre-market-whats-going-on" rel="noreferrer noopener">downgraded the stock</a> to Hold from Buy and lowered its price target from $135 to $120. Curtis&nbsp;identified the increasing rivalry from&nbsp;Intel Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>). A Jefferies benchmarking study showed AMD&#8217;s graphics processing units being significantly outpaced by those of&nbsp;Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>)
in various open-source models.
AMD is under pressure as the US tightens export controls on Chinese firms. The Commerce Department blacklisted over 50 Chinese entities, limiting their access to advanced semiconductors from AMD, affecting its China revenue.
Price Action: AMD stock is down 1.37% at $101.81 at last check Monday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/markets/emerging-markets/25/03/44563420/despite-us-expansion-taiwan-semiconductor-reaffirms-commitment-to-home-base-with-new-initiatives-reuters" target="_blank" rel="noreferrer noopener">Despite US Expansion, Taiwan Semiconductor Reaffirms Commitment To Home Base With New Initiatives: Reuters</a></li>
</ul>
Photo Via AMD

Tech

INTC

NVDA

ORCL

AMD Powers Oracle Cloud With New Epyc Chips Promising Major Boost In Performance

NLS Pharmaceutics Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NLSP#NASDAQ">NLSP</a>) shares are trading higher on Monday after the company announced it secured up to $2 million in equity financing, with a possibility of an additional $1 million, or <a href="https://www.benzinga.com//node/44561503">$1.65 per share</a>.
What To Know: In addition to the $3 million financing agreement, NLS also signed a $25 million committed equity facility agreement. Both funding agreements are intended to support the merger between NLS and Kadimastem.
Specifically, the funding will support Kadimastem&#8217;s Phase IIa multi-site clinical trial for Amyotrophic Lateral Sclerosis using AstroRx and Phase I trial for IsletRx in type 1 diabetes patients.
&#8220;We are pleased to have secured this capital on favorable terms, which reflects investor confidence in our vision and the transformative potential of our planned merger with Kadimastem,&#8221; said Alex Zwyer, CEO of NLS. 
&#8220;We believe that with these financial resources in place, we are well-positioned to move forward with completing the transaction and creating a leading company in the field of regenerative medicine and CNS disorders.&#8221;
See Also: <a href="https://www.benzinga.com/25/03/44566612/palatin-technologies-obesity-drug-co-administered-with-eli-lillys-blockbuster-drug-shows-44-reduction-in-weight-v">Palatin Technologies&#8217; Obesity Drug Co-Administered With Eli Lilly&#8217;s Blockbuster Drug Shows 4.4% Reduction In Weight</a>
NLSP Price Action: At the time of writing, NLS Pharmaceutics stock is trading 13.1% higher at $1.47, according to data from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Image: via Shutterstock

NLSP

What's Going On With NLS Pharmaceutics Shares Monday?

<a href="https://www.foxbusiness.com/video/6370703853112" title="https://www.foxbusiness.com/video/6370703853112">https://www.foxbusiness.com/video/6370703853112</a>

LCID

TSLA

Lucid CEO Says We Are Seeing An Uptick In Orders From Former Tesla Owners- Fox Business Interview

Jefferies analyst Andrew Uerkwitz maintains Unity Software (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/U#NYSE">U</a>) with a Hold and lowers the price target from $28 to $24.

Price Target

Analyst Ratings

Jefferies Maintains Hold on Unity Software, Lowers Price Target to $24

Jefferies analyst Joseph Gallo maintains Radware (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RDWR#NASDAQ">RDWR</a>) with a Hold and lowers the price target from $26 to $24.

RDWR

Jefferies Maintains Hold on Radware, Lowers Price Target to $24

Contracts

L3Harris, Dutch Ministry Of Defence Sign FOXTROT Long-Term Agreement For Up To €1B

Jefferies analyst Joseph Gallo maintains Qualys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QLYS#NASDAQ">QLYS</a>) with a Hold and lowers the price target from $145 to $130.

QLYS

Jefferies Maintains Hold on Qualys, Lowers Price Target to $130

WIIM

SHOT

Safety Shot shares are trading lower after the company CEO provided a business update.

VIGL

Vigil Neuroscience shares are trading lower. The company announced it filed a prospectus regarding a stock offering to sell 5.38 million shares from an existing stockholder.

Jefferies analyst Joseph Gallo maintains Tenable Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TENB#NASDAQ">TENB</a>) with a Hold and lowers the price target from $45 to $37.

TENB

Jefferies Maintains Hold on Tenable Holdings, Lowers Price Target to $37

Whales with a lot of money to spend have taken a noticeably bullish stance on United Parcel Service.
Looking at options history for United Parcel Service (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UPS#NYSE">UPS</a>) we detected 24 trades.
If we consider the specifics of each trade, it is accurate to state that 50% of the investors opened trades with bullish expectations and 41% with bearish.
From the overall spotted trades, 11 are puts, for a total amount of $557,490 and 13, calls, for a total amount of $1,510,948.
<h3>Projected Price Targets</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $90.0 and $150.0 for United Parcel Service, spanning the last three months.
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for United Parcel Service's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of United Parcel Service's whale activity within a strike price range from $90.0 to $150.0 in the last 30 days. 
<h3>United Parcel Service 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743444952_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>UPS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$9.35</td>
<td>$8.9</td>
<td>$8.9</td>
<td>$125.00</td>
<td>$371.1K</td>
<td>1.0K</td>
<td>451</td>
</tr>
<tr>
<td>UPS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$6.65</td>
<td>$6.6</td>
<td>$6.6</td>
<td>$135.00</td>
<td>$304.8K</td>
<td>1.4K</td>
<td>499</td>
</tr>
<tr>
<td>UPS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$3.35</td>
<td>$3.2</td>
<td>$3.25</td>
<td>$115.00</td>
<td>$162.5K</td>
<td>7.0K</td>
<td>768</td>
</tr>
<tr>
<td>UPS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$3.25</td>
<td>$3.15</td>
<td>$3.2</td>
<td>$115.00</td>
<td>$160.0K</td>
<td>7.0K</td>
<td>1.2K</td>
</tr>
<tr>
<td>UPS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$25.4</td>
<td>$25.05</td>
<td>$25.05</td>
<td>$90.00</td>
<td>$125.2K</td>
<td>94</td>
<td>50</td>
</tr>
</tbody>
</table>

<h3>About United Parcel Service</h3>
As the world's largest parcel delivery company, UPS manages a massive fleet of more than 500 planes and 100,000 vehicles, along with many hundreds of sorting facilities, to deliver an average of about 22 million packages per day to residences and businesses across the globe. UPS' domestic US package operations generate around 65% of total revenue while international package makes up 20%. Air and ocean freight forwarding and contract logistics make up the remainder.
Having examined the options trading patterns of United Parcel Service, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Present Market Standing of United Parcel Service</h3>
<ul>
<li>With a trading volume of 2,291,605, the price of UPS is down by -0.88%, reaching $108.7.</li>
<li>Current RSI values indicate that the stock is may be approaching oversold.</li>
<li>Next earnings report is scheduled for 29 days from now.</li>
</ul>
<h3>What Analysts Are Saying About United Parcel Service</h3>
Over the past month, 4 industry analysts have shared their insights on this stock, proposing an average target price of $119.75.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Wells Fargo keeps a Overweight rating on United Parcel Service with a target price of $120. 
&#x2A; Reflecting concerns, an analyst from Truist Securities lowers its rating to Buy with a new price target of $140. 
&#x2A; Consistent in their evaluation, an analyst from Barclays keeps a Underweight rating on United Parcel Service with a target price of $90. 
&#x2A; Maintaining their stance, an analyst from B of A Securities continues to hold a Buy rating for United Parcel Service, targeting a price of $129. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for United Parcel Service with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

Options

This Is What Whales Are Betting On United Parcel Service

Benzinga's options scanner has just identified more than 8 option transactions on Cava Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAVA#NYSE">CAVA</a>), with a cumulative value of $959,910. Concurrently, our algorithms picked up 3 puts, worth a total of 745,410.
<h3>Expected Price Movements</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $60.0 and $110.0 for Cava Group, spanning the last three months.
<h3>Volume &amp; Open Interest Trends</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Cava Group's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Cava Group's significant trades, within a strike price range of $60.0 to $110.0, over the past month.
<h3>Cava Group Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743444947_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CAVA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$10.95</td>
<td>$8.7</td>
<td>$9.5</td>
<td>$110.00</td>
<td>$1.9M</td>
<td align="right">464</td>
<td>2.0K</td>
</tr>
<tr>
<td>CAVA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/09/25</td>
<td>$1.01</td>
<td>$0.67</td>
<td>$0.73</td>
<td>$65.00</td>
<td>$688.8K</td>
<td align="right">0</td>
<td>8.9K</td>
</tr>
<tr>
<td>CAVA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$33.0</td>
<td>$32.4</td>
<td>$33.0</td>
<td>$60.00</td>
<td>$99.0K</td>
<td align="right">730</td>
<td>33</td>
</tr>
<tr>
<td>CAVA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$1.93</td>
<td>$1.43</td>
<td>$1.79</td>
<td>$91.00</td>
<td>$44.7K</td>
<td align="right">360</td>
<td>253</td>
</tr>
<tr>
<td>CAVA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$7.85</td>
<td>$7.6</td>
<td>$7.75</td>
<td>$85.00</td>
<td>$38.7K</td>
<td align="right">497</td>
<td>102</td>
</tr>
</tbody>
</table>

<h3>About Cava Group</h3>
Cava Group Inc owns and operates a chain of restaurants. It is the category-defining Mediterranean fast-casual restaurant brand, bringing together healthful food and bold, satisfying flavors at scale. The company's dips, spreads, and dressings are centrally produced and sold in grocery stores. The company's operations are conducted as two reportable segments: CAVA and Zoes Kitchen. The company generates all of its revenue from the CAVA segment.
Following our analysis of the options activities associated with Cava Group, we pivot to a closer look at the company's own performance.
<h3>Cava Group's Current Market Status</h3>
<ul>
<li>With a trading volume of 2,596,501, the price of CAVA is down by 0.0%, reaching $85.85.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 57 days from now.</li>
</ul>
<h3>What Analysts Are Saying About Cava Group</h3>
Over the past month, 2 industry analysts have shared their insights on this stock, proposing an average target price of $111.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Reflecting concerns, an analyst from B of A Securities lowers its rating to Buy with a new price target of $112. 
&#x2A; An analyst from JP Morgan has elevated its stance to Overweight, setting a new price target at $110. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Cava Group, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

CAVA

Cava Group Options Trading: A Deep Dive into Market Sentiment

Investors with significant funds have taken a bullish position in UP Fintech Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIGR#NASDAQ">TIGR</a>), a development that retail traders should be aware of.
This was brought to our attention today through our monitoring of publicly accessible options data at Benzinga. The exact nature of these investors remains a mystery, but such a major move in TIGR usually indicates foreknowledge of upcoming events.
Today, Benzinga's options scanner identified 41 options transactions for UP Fintech Holding. This is an unusual occurrence. The sentiment among these large-scale traders is mixed, with 85% being bullish and 12% bearish. Of all the options we discovered, 40 are puts, valued at $4,352,142, and there was a single call, worth $169,974.
<h3>Expected Price Movements</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $8.0 to $9.0 for UP Fintech Holding over the last 3 months. 
<h3>Volume &amp; Open Interest Trends</h3>
In terms of liquidity and interest, the mean open interest for UP Fintech Holding options trades today is 11084.25 with a total volume of 480,126.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for UP Fintech Holding's big money trades within a strike price range of $8.0 to $9.0 over the last 30 days.
<h3>UP Fintech Holding Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743444942_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>TIGR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/17/25</td>
<td>$1.49</td>
<td>$1.45</td>
<td>$1.45</td>
<td>$8.00</td>
<td>$435.3K</td>
<td>444</td>
<td>7.3K</td>
</tr>
<tr>
<td>TIGR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/17/25</td>
<td>$1.49</td>
<td>$1.44</td>
<td>$1.44</td>
<td>$8.00</td>
<td>$288.2K</td>
<td>444</td>
<td>20.3K</td>
</tr>
<tr>
<td>TIGR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/17/25</td>
<td>$1.43</td>
<td>$1.4</td>
<td>$1.4</td>
<td>$8.00</td>
<td>$183.9K</td>
<td>444</td>
<td>27.3K</td>
</tr>
<tr>
<td>TIGR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$1.04</td>
<td>$1.03</td>
<td>$1.04</td>
<td>$9.00</td>
<td>$173.4K</td>
<td>458</td>
<td>1.6K</td>
</tr>
<tr>
<td>TIGR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$1.36</td>
<td>$1.28</td>
<td>$1.34</td>
<td>$9.00</td>
<td>$169.9K</td>
<td>32.1K</td>
<td>701</td>
</tr>
</tbody>
</table>

<h3>About UP Fintech Holding</h3>
UP Fintech Holding Ltd is an online brokerage firm focusing on Chinese investors. Its trading platform enables investors to trade in equities and other financial instruments on multiple exchanges of stocks and other derivatives. The company offers its customers brokerage and value-added services, including trade order placement and execution, margin financing, account management, investor education, community discussion, and customer support.
Having examined the options trading patterns of UP Fintech Holding, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Current Position of UP Fintech Holding</h3>
<ul>
<li>With a trading volume of 5,029,455, the price of TIGR is down by -3.56%, reaching $8.36.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 65 days from now.</li>
</ul>
<h3>What The Experts Say On UP Fintech Holding</h3>
A total of 1 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $9.5.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; In a positive move, an analyst from Citigroup has upgraded their rating to Neutral and adjusted the price target to $9. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for UP Fintech Holding with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

TIGR

UP Fintech Holding Unusual Options Activity

BCAB

BioAtla shares are trading lower after Citizens Capital Markets cut its price target on the stock from $5 to $1.

Jefferies analyst Joseph Gallo maintains Rapid7 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPD#NASDAQ">RPD</a>) with a Buy and lowers the price target from $45 to $35.

Jefferies Maintains Buy on Rapid7, Lowers Price Target to $35

APLM

Apollomics shares are trading higher after the company announced a development and commercialization agreement for Vebreltinib.

IMCC

IM Cannabis shares are trading lower after the company reported worse-than-expected Q4 sales results.

Chicago Rivet & Machine shares are trading lower after the company reported a year-over-year decrease in FY24 financial results.

Jefferies analyst Joseph Gallo maintains Varonis Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRNS#NASDAQ">VRNS</a>) with a Hold and lowers the price target from $50 to $45.

VRNS

Jefferies Maintains Hold on Varonis Systems, Lowers Price Target to $45

Press Releases

"Stocks Under $1 Gaining Momentum: WBUY, KAVL, OMEX, PRTG, RJDG – Driving Innovation, Market Trends, and Growth Potential"

Portage Biotech Reports Results for Fiscal Quarter Ended September 30, 2024

Portage Biotech Announces Receipt of Nasdaq Noncompliance Letter

Portage Biotech Announces Letter of Intent with Immunova for an Option to Acquire iOx Therapeutics, Ltd

Management

General

Portage Biotech Announce Re-Launch of Adenosine Subsidiary as Independently Managed Company; Appointment of Peter Molloy to Lead New Company

Financing

Portage Biotech Announces Completion of $2.15 Million Private Financing

Portage Biotech Receives Extension of Time to Attain Compliance With Stock Exchange Continued Listing Requirements

Portage Biotech Resumes Enrollment in Final Cohort of Dose Escalation for Port-6 in ADPORT-601 Trial

Health Care

Portage Biotech Reports Promising Preclinical Results in Mesothelioma Supporting First-In-Human Trial of PORT-7

Emerging Tech Quartet – PRSO, LXRX, PRTG, RNAZ – Drive Breakthroughs Across Defense, Obesity, Oncology, and RNA Therapeutics

Comments

Portage Biotech

Interés en corto

Portage Biotech (NASDAQ:PRTG) Bolsa, Informe de interés en corto

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL